Patents by Inventor David Aldous
David Aldous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130312316Abstract: The present invention provides useful cooking and/or heating fuel compositions which may be produced substantially from renewable resources, such as biomass, to provide green fuel compositions, methods, and systems. The fuel compositions include gases stored under pressure, liquids, and gels/gelled waxes. Gases and liquids can include dimethyl ether and one or more C2 or larger alcohols, or can include dimethyl ether and one or more C2 or larger hydrocarbons. Gels and gelled waxes can include dimethyl ether and/or one or more C1-4 alcohols and wax or a gel. Methods of making these fuel compositions, particularly from biomass-derived syngas, are also described. Various applications and methods of using the fuel compositions, such as portable cylinder fuels for camping, are disclosed. Additionally, principles of burner design for these fuel compositions are disclosed herein.Type: ApplicationFiled: July 24, 2013Publication date: November 28, 2013Applicant: Maverick Biofuels, Inc.Inventors: Ronald C. STITES, David ALDOUS, David S. BRADIN, Eric CUMMING
-
Publication number: 20130055628Abstract: The present invention provides useful fuel compositions which may be produced substantially from renewable resources, such as biomass, to provide green fuel compositions, methods, and systems. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger alcohol, such as ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutanol, or tent-butanol. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger hydrocarbons, such as propane, propylene, propyne, and propadiene, n-butane, isobutane, isobutylene, 1-butene, 2-butene, or 1,3-butadiene. Methods of making these novel DME-based fuel compositions, particularly from biomass-derived syngas, are described. Various applications and methods of using the fuel compositions, such as portable cylinder fuels for camping, are disclosed. Additionally, principles of burner design for these fuel compositions are disclosed herein.Type: ApplicationFiled: October 19, 2012Publication date: March 7, 2013Applicant: MAVERICK BIOFUELS, INC.Inventors: Ronald C. STITES, David ALDOUS
-
Patent number: 8187705Abstract: Manganese vanadium tantalum oxide that can be represented by the formula MnxVyTazOw, where 1?x?3, 0.001?y?3, 0.001?z?2, and w=7, and alternately, x=1.25?x?2.45, 0.1?y?2.39, 0.2?z?1.9, and w=7, methods of producing MnxVyTazOw, a pigment coated with MnxVyTazOw and a chalcogenide glass layer, and a method of producing the coated pigment are described. The disclosed manganese vanadium tantalum oxide has superior near-infrared reflective properties. The disclosed methods of producing the manganese vanadium tantalum oxide provide products with superior phase purity, appearance and performance and take health and safety into consideration. The construction of the disclosed coated pigment combines the reflective properties of the substrate with the near-infrared reflective properties of MnxVyTazOw, while the chalcogenide glass layer provides aesthetic appeal. The disclosed method of producing the coated pigment involves physical vapor deposition of MnxVyTazOw and the chalcogenide glass layer.Type: GrantFiled: July 15, 2010Date of Patent: May 29, 2012Assignee: Silberline Manufacturing Company, Inc.Inventors: Stewart Warrender, Hai Hui Lin, Parfait Jean Marie Likibi, Rajasekar Pitchimani, Devidas Balu Raskar, David Aldous
-
Publication number: 20120047796Abstract: The present invention provides useful fuel compositions which may be produced substantially from renewable resources, such as biomass, to provide green fuel compositions, methods, and systems. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger alcohol, such as ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutanol, or tert-butanol. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger hydrocarbons, such as propane, propylene, propyne, and propadiene, n-butane, isobutane, isobutylene, 1-butene, 2-butene, or 1,3-butadiene. Methods of making these novel DME-based fuel compositions, particularly from biomass-derived syngas, are described. Various applications and methods of using the fuel compositions, such as portable cylinder fuels for camping, are disclosed. Additionally, principles of burner design for these fuel compositions are disclosed herein.Type: ApplicationFiled: November 8, 2011Publication date: March 1, 2012Applicant: RANGE FUELS, INC.Inventors: Ronald C. STITES, David ALDOUS
-
Publication number: 20120016058Abstract: Manganese vanadium tantalum oxide that can be represented by the formula MnxVyTazOw, where 1?x?3, 0.001?y?3, 0.001?z?2, and w=7, and alternately, x=1.25?x?2.45, 0.1?y?2.39, 0.2?z?1.9, and w=7, methods of producing MnxVyTazOw, a pigment coated with MnxVyTazOw and a chalcogenide glass layer, and a method of producing the coated pigment are described. The disclosed manganese vanadium tantalum oxide has superior near-infrared reflective properties. The disclosed methods of producing the manganese vanadium tantalum oxide provide products with superior phase purity, appearance and performance and take health and safety into consideration. The construction of the disclosed coated pigment combines the reflective properties of the substrate with the near-infrared reflective properties of MnxVyTazOw, while the chalcogenide glass layer provides aesthetic appeal. The disclosed method of producing the coated pigment involves physical vapor deposition of MnxVyTazOw, and the chalcogenide glass layer.Type: ApplicationFiled: July 15, 2010Publication date: January 19, 2012Applicant: SILBERLINE MANUFACTURING COMPANY, INC.Inventors: Stewart James WARRENDER, Hai Hui LIN, Parfait Jean Marie LIKIBI, Rajasekar PITCHIMANI, Devidas Balu RASKAR, David ALDOUS
-
Publication number: 20070203138Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: ApplicationFiled: April 26, 2007Publication date: August 30, 2007Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Inventors: Jiayo Li, David Aldous, Sukanthini Thurairatnam
-
Publication number: 20070142417Abstract: The present invention is directed to the substantially pure compound of formula (A), or pharmaceutically acceptable salt, or solvate of said compound; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (A), and a pharmaceutically acceptable carrier; and the use of a compound of formula (A) having activity as an inhibitor, preferably a selective inhibitor, of I?B (IKK), particularly IKK-2, and methods related thereto.Type: ApplicationFiled: November 13, 2006Publication date: June 21, 2007Applicant: AVENTIS PHARMACEUTICALS INCInventors: El-Bdaoui HADDAD, Olaf Ritzeler, David Aldous, Paul Cox
-
Publication number: 20070135386Abstract: The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: ApplicationFiled: January 22, 2007Publication date: June 14, 2007Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals Inc.Inventors: Michael Graupe, James Palmer, David Aldous, Sukanthini Thurairatnam
-
Publication number: 20070049594Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: ApplicationFiled: December 7, 2005Publication date: March 1, 2007Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Inventors: Michael Graupe, John Patterson, David Aldous, Sukanthini Thurairatnam, Andreas Timm, John Link, Jiayao Li, Stephen Pickett, Frank Halley, Justine Lai
-
Publication number: 20060189657Abstract: Novel inhibitors of cathepsin S, K, B, and L, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: ApplicationFiled: April 24, 2006Publication date: August 24, 2006Applicant: Aventis Pharmaceuticals Inc.Inventors: Sukanthini Thurairatnam, David Aldous, Vincent Leroy, Andreas Timm
-
Patent number: 7064123Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: GrantFiled: December 24, 2001Date of Patent: June 20, 2006Assignees: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Inventors: Michael Graupe, John W. Patterson, Stephen D. Pickett, John O. Link, Jiayao Li, David Aldous, Sukanthini Thurairatnam, Andreas P. Timm, Frank Halley, Justine Lai Yeun Quai
-
Publication number: 20060089357Abstract: The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: ApplicationFiled: December 7, 2005Publication date: April 27, 2006Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Inventors: Michael Graupe, James Palmer, John Patterson, Stephen Pickett, David Aldous, Sukanthini Thurairatnam, Andreas Timm, Frank Halley, Justine Lai, John Link, Jiayao Li
-
Publication number: 20050267044Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.Type: ApplicationFiled: June 24, 2005Publication date: December 1, 2005Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.Inventors: Jiayo Li, David Aldous, Sukanthini Thurairatnam
-
Publication number: 20050038069Abstract: This invention is directed to physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; R1 represents hydrogen or a straight- or branched-chain alkyl group of 1 to about 4 carbon atoms, optionally substituted by hydroxy or one or more halogen atoms, or when Z1 represents a direct bond R1 may also represent a lower alkenyl or lower alkynyl group, or a formyl group; R2 represents hydrogen, alkenyl, alkoxy, alkyl, alkylsulphinyl, alkylsulphonyl, alkylthio, aryl, arylalkyloxy, arylalkylsulphinyl, arylalkylsulphonyl, arylalkylthio, aryloxy, arylsulphinyl, arylsulphonyl, arylthio, cyano, cycloalkenyl, cycloalkenyloxy, cycloalkyl, cycloalkyloxy, heteroaryl, heteroarylalkyloxy, heteroaryloxy, hydroxy, —SO2NR4R5, —NR4SO2R5, —NR4R5, —C(?O)R5, —C(?O)C(?O)R5, —C(?O)NR4R5, —C(?O)OR5, —O(C?O)NR4R5, orType: ApplicationFiled: September 1, 2004Publication date: February 17, 2005Applicant: AVENTIS PHARMA LIMITEDInventors: Paul Cox, Shelley Bower, David Aldous, Peter Astles, Daniel McGarry, Christopher Hulme, John Regan, Fu-Chih Huang, Stevan Djuric, Kevin Moriarty, Rose Mathew, Gregory Poli
-
Publication number: 20050009831Abstract: The present invention concerns compounds of general formula (I): in which: R1 represents hydrogen, R4, —C(?Y)—NHR4, —SO2NHR4, —C(=Z1)—R4, —SO2—R4 or —C(=Z1)—OR4; R2 represents hydrogen, cyano, halogen or —C?C—R5; R3 represents hydrogen, acyl, alkoxycarbonyl, alkyl, aroyl, aryl, aryloxycarbonyl, carboxy, cycloalkenyl, cycloalkyl, heteroaroyl, heteroaryl, heterocycloalkyl or —C(?O)—NY1Y2; R4 represents optionally substituted alkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, aryl or heteroaryl R5 represents hydrogen or alkyl; R6 represents alkyl, acyl, alkoxycarbonyl, alkylsulfonyl, aryl, arylsulfonyl, aroyl, cycloalkyl, cycloalkenyl, heteroaryl, heteroarylsulfonyl, heteroaroyl and heterocycloalkyl; R7 represents optionally substituted alkyl, cycloalkyl or cycloalkylalkyl, R8 represents hydrogen, alkyl, alkenyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R9 represents alkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl or heterocycloalkylalkyl;Type: ApplicationFiled: March 18, 2004Publication date: January 13, 2005Applicant: Aventis Pharma S.A,Inventors: Andrew Ratcliffe, Roger Aitchison Walsh, Tahir Majid, Sukanthini Thurairatnam, Shelley Amendola, David Aldous, John Souness, Conception Nemecek, Sylvie Wentzler, Corinne Venot